NOVOSENSE sets 27 April 2026 board meeting to approve Q1 2026 results
Bulletin Express
Apr 14
Suzhou Novosense Microelectronics Co., Ltd. (NOVOSENSE) has announced that its board of directors will convene on 27 April 2026.
The agenda includes consideration and approval of the consolidated results for the three months ended 31 March 2026, followed by their release to the market. The meeting will also handle any additional corporate matters.
NOVOSENSE’s board currently comprises four executive directors (Wang Shengyang, Sheng Yun, Wang Yifeng, Jiang Chaoshang), one non-executive director (Wu Jie) and four independent non-executive directors (Dr. Hong Zhiliang, Dr. Chen Xichan, Wang Ruwei, Du Linlin).
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.